X4 Pharmaceuticals, Inc. · NASDAQ:XFOR
BVF PARTNERS L P/IL reported a 9.90% stake in X4 Pharmaceuticals, Inc. (Schedule 13G)
Event Aug 13, 2025 · Filed Aug 20, 2025
BVF PARTNERS L P/IL reported a 9.90% stake in X4 Pharmaceuticals, Inc., 2,243,659 shares, as a passive investor on Aug 13, 2025. Filed Aug 20, 2025 (Schedule 13G).
- Stake
- 9.90%
- Shares
- 2,243,659
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 10 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BIOTECHNOLOGY VALUE FUND L P | 5.20% | 1,168,649 |
| BVF I GP LLC | 5.20% | 1,168,649 |
| BIOTECHNOLOGY VALUE FUND II LP | 4.00% | 906,855 |
| BVF II GP LLC | 4.00% | 906,855 |
| Biotechnology Value Trading Fund OS LP | 0.60% | 123,369 |
| BVF Partners OS Ltd. | 0.60% | 123,369 |
| BVF GP HOLDINGS LLC | 9.20% | 2,075,504 |
| BVF PARTNERS L P/IL | 9.90% | 2,243,659 |
| BVF INC/IL | 9.90% | 2,243,659 |
| LAMPERT MARK N | 9.90% | 2,243,659 |
Source
Related
- X4 Pharmaceuticals, Inc.
- Bvf Partners L P
- X4 Pharmaceuticals, Inc. shareholders
- Schedule 13G/A · Bvf Partners L P · Feb 17, 2026
- Form 4 · Craig Adam R · Oct 19, 2026
- Schedule 13G/A · FMR LLC · Oct 7, 2026
- Form 4 · Kirske David · Oct 5, 2026
- Schedule 13G · Venrock Healthcare Capital Partners III, L.P. · Sep 21, 2026
- Schedule 13G/A · Deep Track Capital, LP · Aug 14, 2026